Showing 1,041 - 1,060 results of 116,192 for search '(( a non decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.87s Refine Results
  1. 1041
  2. 1042
  3. 1043
  4. 1044
  5. 1045
  6. 1046
  7. 1047
  8. 1048
  9. 1049

    Viability of <i>MRE11</i>, <i>mre11A470T</i>, <i>rap1-5</i>, <i>and mre11A470T rap1-5</i>. by In-Joon Baek (4423057)

    Published 2017
    “…<i>mre11A470T</i> and <i>mre11A470T rap1-5</i> cells had decreased viability only at 37°C. …”
  10. 1050
  11. 1051
  12. 1052
  13. 1053
  14. 1054
  15. 1055
  16. 1056
  17. 1057

    EIF5A2 or MTA1 expression levels influenced the aggressiveness of GC cells in vitro. by Qing-Bin Meng (707083)

    Published 2015
    “…<p>(<b>A</b>) Proliferation of EIF5A2-targeted siRNA (T1-siRNA) and non-targeted control (NC) HGC27 cells were measured by CCK-8 assay every 24 h after siRNA transfection. …”
  18. 1058

    Image_1_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF by Hilde L. Orrem (5740313)

    Published 2018
    “…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”
  19. 1059

    Image_2_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF by Hilde L. Orrem (5740313)

    Published 2018
    “…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”
  20. 1060

    Table_1_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.DOCX by Hilde L. Orrem (5740313)

    Published 2018
    “…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”